Filing Details
- Accession Number:
- 0001237899-12-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-01 12:34:01
- Reporting Period:
- 2012-05-30
- Filing Date:
- 2012-06-01
- Accepted Time:
- 2012-06-01 12:34:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225471 | L George Sing | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-05-30 | 5,000 | $134.00 | 142,772 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-05-31 | 3,300 | $134.74 | 139,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-05-31 | 1,700 | $135.15 | 137,772 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | by Son |
Footnotes
- Represents volume-weighted average price of sales of 3,300 shares of Company stock on May 31, 2012 at prices ranging from $134.44 to $134.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 31, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,700 shares of Company stock on May 31, 2012 at prices ranging from $135.01 to $135.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 31, 2012 at each separate price.
Billionaire Hedge Funds
